AQR Capital Management LLC Increases Stake in Pediatrix Medical Group, Inc. $MD

Key Points

• AQR Capital Management LLC increased its stake in Pediatrix Medical Group by 3.3%, owning approximately 0.53% of the company worth $6,466,000 after acquiring an additional 14,799 shares.
• Pediatrix Medical Group reported earnings per share (EPS) of $0.53 for the last quarter, surpassing the consensus estimate of $0.42, but noted a 7.1% year-over-year revenue decline.
• Multiple financial institutions, including BNP Paribas Financial Markets and Deutsche Bank AG, have significantly raised their stakes in Pediatrix Medical Group, reflecting increased institutional interest in the company.

AQR Capital Management LLC boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 3.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 458,880 shares of the company's stock after purchasing an additional 14,799 shares during the period. AQR Capital Management LLC owned approximately 0.53% of Pediatrix Medical Group worth $6,466,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Northern Trust Corp raised its stake in shares of Pediatrix Medical Group by 18.0% in the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company's stock valued at $12,678,000 after acquiring an additional 147,522 shares during the period. BNP Paribas Financial Markets raised its position in Pediatrix Medical Group by 87.8% in the fourth quarter. BNP Paribas Financial Markets now owns 34,776 shares of the company's stock valued at $456,000 after purchasing an additional 16,256 shares during the period. Deutsche Bank AG raised its holdings in shares of Pediatrix Medical Group by 53.1% during the 4th quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock valued at $971,000 after buying an additional 25,663 shares during the period. Graham Capital Management L.P. purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at about $463,000. Finally, Gotham Asset Management LLC raised its stake in shares of Pediatrix Medical Group by 38.0% during the fourth quarter. Gotham Asset Management LLC now owns 54,642 shares of the company's stock valued at $717,000 after purchasing an additional 15,044 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $17.04 on Friday. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. The business has a 50 day moving average of $14.69 and a two-hundred day moving average of $14.17. Pediatrix Medical Group, Inc. has a 52 week low of $10.39 and a 52 week high of $17.67. The company has a market cap of $1.48 billion, a P/E ratio of 13.21 and a beta of 1.30.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.11. The company had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company's revenue for the quarter was down 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 earnings per share. As a group, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Ratings Changes

MD has been the topic of several analyst reports. UBS Group lifted their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Zacks Research raised Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Finally, Leerink Partners lifted their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $16.79.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.